Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.587 USD | +0.93% |
|
-8.38% | -27.60% |
Jul. 01 | HOOKIPA Pharma Reports First Patient Dosed in HIV Treatment Study | MT |
Jul. 01 | HOOKIPA Pharma Inc. Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.60% | 57.55M | |
+52.26% | 816B | |
+38.59% | 634B | |
-7.34% | 351B | |
+15.38% | 323B | |
+5.65% | 293B | |
+13.40% | 238B | |
+0.61% | 222B | |
+13.24% | 218B | |
+6.58% | 167B |
- Stock Market
- Equities
- HOOK Stock
- News HOOKIPA Pharma Inc.
- RBC Trims Price Target on HOOKIPA Pharma to $7 From $8, Affirms Outperform Rating